Version 1 of 68 (2001-01-18 to 2002-01-30) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Corporation: |
HOFFMANN-LA ROCHE LIMITED
2455 MEADOWPINE BLVD. MISSISSAUGA, ON L5N 6L7 Canada |
| Telephone number: | 905-542-5555 |
| Fax number: | 905-542-7130 |
| Responsible officer name and position during the period of this registration: | RONNIE MILLER, PRESIDENT AND CEO |
| Description of activities: | PHARMACEUTICALS, VITAMINS & FINE CHEMICALS, DIAGNOSTICS, FLAVOURS AND FEED PRE-MIXES |
| The client is a subsidiary of the following parent companies: |
F. HOFFMANN-LA ROCHE LIMITED
POSTFACH 4002 BASEL Switzerland |
| Coalition | The corporation is not a member of a coalition. |
| Subsidiary: | The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking. |
| Other direct interests | The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
| Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Health Canada (HC), Industry Canada |
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Meetings, Written communications, whether in hard copy or electronic format |
| Subject Matter: Areas of Concern: | Health, Intellectual Property, International Relations |
| Subject Matter: Particulars: | BILLS OR RESOLUTIONS RE: REVIEW OF DRUG PATENT LEGISLATION (FORMERLY BILL C-91) |